Related Experiment Video
Updated: May 14, 2026
13:10
DNA Vector-based RNA Interference to Study Gene Function in Cancer
Published on: June 4, 2012
[RNA interference library research progress and its application in cancer research]
1Department of Medical Oncology, the Third Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|February 22, 2013
Summary
RNA interference (RNAi) technology enables targeted mRNA degradation. RNAi libraries are crucial tools advancing genetic and cancer research by enabling systematic gene function studies.
Area of Science:
- Molecular Biology
- Genetics
Context:
- RNA interference (RNAi) is a natural biological process involving the degradation of messenger RNA (mRNA) by double-stranded RNA (dsRNA).
- RNAi technology has been harnessed to create artificial pooled libraries for high-throughput genetic screening.
Purpose:
- To review the research progress and applications of RNAi libraries in medical research.
- To highlight the significance of RNAi libraries in the field of cancer research.
Summary:
- RNAi libraries are constructed using RNA interference technology for systematic gene knockdown.
- These libraries represent a significant advancement in genetic research, enabling functional genomics studies.
- The review covers the development and diverse applications of RNAi libraries, particularly in oncology.
Impact:
- RNAi libraries provide powerful tools for understanding gene function and disease mechanisms.
- Their application in cancer research accelerates the identification of therapeutic targets and drug discovery.
- This technology facilitates breakthroughs in genetic research and personalized medicine.
More Related Videos
Related Concept Videos
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...